Upgrade to SI Premium - Free Trial

AxoGen (AXGN)

36.48 +0.31 (0.86%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/28/26)

Latest Headlines

Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026 October 14, 2026 7:00 AM - StreetInsider BofA Securities Starts AxoGen, Inc. (AXGN) at Buy October 12, 2026 6:08 AM - StreetInsider Barclays Starts AxoGen, Inc. (AXGN) at Overweight October 6, 2026 4:25 PM - StreetInsider Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why. October 6, 2026 9:06 AM - StreetInsider Form SCHEDULE 13G Axogen, Inc. Filed by: Divisadero Street Capital Management, LP October 2, 2026 5:36 PM - SEC Filing Form 8-K Axogen, Inc. For: Oct 01 October 1, 2026 5:25 PM - SEC Filing Axogen acquires BioCircuit, adding sutureless nerve repair device October 1, 2026 5:19 PM - StreetInsider Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair October 1, 2026 5:19 PM - Globe NewsWire AxoGen, Inc. (AXGN) PT Lowered to $53 at Truist Securities October 1, 2026 5:23 AM - StreetInsider Truist Securities Reiterates Buy Rating on AxoGen, Inc. (AXGN) September 29, 2026 5:06 AM - StreetInsider AxoGen, Inc. (AXGN) PT Raised to $53 at Raymond James September 25, 2026 5:05 AM - StreetInsider Form 424B5 Axogen, Inc. September 10, 2026 4:57 PM - SEC Filing Form 8-K/A Axogen, Inc. For: Sep 09 September 10, 2026 4:55 PM - SEC Filing Form 8-K Axogen, Inc. For: Sep 09 September 10, 2026 6:04 AM - SEC Filing Axogen prices $208.7M stock offering to fund BioCircuit acquisition September 10, 2026 6:01 AM - StreetInsider Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock September 10, 2026 6:01 AM - StreetInsider Axogen to acquire BioCircuit Technologies for $200M in cash September 10, 2026 6:00 AM - StreetInsider Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies September 10, 2026 6:00 AM - StreetInsider Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference September 1, 2026 7:00 AM - StreetInsider Truist Securities Starts AxoGen, Inc. (AXGN) at Buy August 26, 2026 5:02 AM - StreetInsider Form SCHEDULE 13G/A Axogen, Inc. Filed by: First Light Asset Management, LLC August 14, 2026 4:41 PM - SEC Filing Form 4 Axogen, Inc. For: Aug 10 Filed by: Began Marc A August 12, 2026 4:14 PM - SEC Filing Form 4 Axogen, Inc. For: Aug 11 Filed by: Wendell Amy McBride August 12, 2026 4:13 PM - SEC Filing Form 144 Axogen, Inc. Filed by: Wendell Amy McBride August 11, 2026 4:30 PM - SEC Filing Form 4 Axogen, Inc. For: Aug 07 Filed by: Weiler Kathy Johnson August 11, 2026 4:16 PM - SEC Filing Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It August 11, 2026 3:36 PM - StreetInsider Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It August 11, 2026 3:35 PM - Globe NewsWire Form 144 Axogen, Inc. Filed by: Began Marc A August 10, 2026 4:33 PM - SEC Filing Form 144 Axogen, Inc. Filed by: Weiler Kathy Johnson August 7, 2026 4:37 PM - SEC Filing Mizuho refreshes Americas Top Picks with five new high-conviction stock ideas August 5, 2026 4:00 PM - StreetInsider Form SCHEDULE 13G/A Axogen, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC July 31, 2026 9:56 AM - SEC Filing AxoGen, Inc. (AXGN) PT Raised to $58 at Mizuho July 30, 2026 7:10 AM - StreetInsider AxoGen, Inc. (AXGN) PT Raised to $53 at H.C. Wainwright July 30, 2026 6:45 AM - StreetInsider AxoGen, Inc. (AXGN) PT Raised to $55 at Citizens on Q2 Performance July 30, 2026 4:53 AM - StreetInsider Form 10-Q Axogen, Inc. For: Jun 30 July 29, 2026 4:14 PM - SEC Filing AxoGen, Inc. (AXGN) PT Raised to $55 at Canaccord July 29, 2026 3:39 PM - StreetInsider AxoGen (AXGN) Misses Q2 EPS by 24c July 29, 2026 7:34 AM - StreetInsider Form 8-K Axogen, Inc. For: Jul 29 July 29, 2026 7:11 AM - SEC Filing Axogen invests in Trace Biosciences nerve imaging technology July 29, 2026 7:10 AM - StreetInsider Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology July 29, 2026 7:10 AM - PR NewsWire Axogen, Inc. Reports Second Quarter 2026 Financial Results July 29, 2026 7:05 AM - StreetInsider Full Article List